JBHT
53
-5
STI
18
-31
CCL
65
-7
VFC
68
-4
PH
56
-17
LRCX
71
-6
O
57
6
HIG
56
5
INTC
56
-2
RCL
70
-13
STX
78
-7
RL
60
-22
TSN
55
-12
QCOM
31
-24
HCA
57
2
ABT
30
3
IVZ
40
-2
NWL
52
3
XRAY
25
-12
ED
55
3
JBHT
53
-5
STI
18
-31
CCL
65
-7
VFC
68
-4
PH
56
-17
LRCX
71
-6
O
57
6
HIG
56
5
INTC
56
-2
RCL
70
-13
STX
78
-7
RL
60
-22
TSN
55
-12
QCOM
31
-24
HCA
57
2
ABT
30
3
IVZ
40
-2
NWL
52
3
XRAY
25
-12
ED
55
3
Financhill
Back

Virtus LifeSci Biotech Clinical Trials ETF Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
80

BBC
Virtus LifeSci Biotech Clinical Trials ETF

Last Price:
$40.85
Seasonality Move:
-1.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Virtus LifeSci Biotech Clinical Trials ETF Stock Forecast

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 11.8% based on the past 11 years of stock performance.
  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
  • Is Virtus LifeSci Biotech Clinical Trials ETF Stock Undervalued?
    The current Virtus LifeSci Biotech Clinical Trials ETF [BBC] share price is $40.84. The Score for BBC is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • BBC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Virtus LifeSci Biotech Clinical Trials ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 11.8% based on the past 11 years of stock performance.

Virtus LifeSci Biotech Clinical Trials ETF Stock Rating

Buy
80
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is a Buy

Is Virtus LifeSci Biotech Clinical Trials ETF overpriced?

  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%

Virtus LifeSci Biotech Clinical Trials ETF Stock Price History

Is BBC stock going to rise?

  • The current trend is moderately bearish and BBC is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
44.10
52-Week Low:
13.42

Prediction Charts

Market Cap:
0
Price in USD:
40.84
Volume:
22K
Beta:
1.30

Technical Analysis

SMA50:
38.79
SMA100:
33.55
SMA200:
26.78
52-Wk Change:
75.53%

Stock Predictions

  • Is Virtus LifeSci Biotech Clinical Trials ETF stock public?
    Yes, Virtus LifeSci Biotech Clinical Trials ETF is a publicly traded company.
  • What is the Virtus LifeSci Biotech Clinical Trials ETF stock quote today?
    The Virtus LifeSci Biotech Clinical Trials ETF stock price is 40.84 USD today.
  • How to buy Virtus LifeSci Biotech Clinical Trials ETF stock online?
    You can buy Virtus LifeSci Biotech Clinical Trials ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-12 39.48 39.37 39.48 38.40
Jan-13 39.06 39.82 39.91 38.83
Jan-14 39.81 41.49 41.49 39.81
Jan-15 41.61 40.36 41.61 40.36
Jan-16 40.53 40.58 41.04 40.05
Jan-20 40.10 41.59 41.61 39.73
Jan-21 41.63 42.37 42.37 41.31
Jan-22 42.77 43.90 44.10 42.77
Jan-23 44.08 42.77 44.08 42.71
Jan-26 42.34 42.10 42.38 41.52
Jan-27 42.01 42.80 42.88 42.01
Jan-28 42.93 41.45 42.94 41.45
Jan-29 41.46 41.50 41.88 41.11
Jan-30 41.29 40.84 41.69 40.43

Virtus LifeSci Biotech Clinical Trials ETF Earnings

Data Unavailable

Virtus LifeSci Biotech Clinical Trials ETF Forecast Revenue Growth

Data Unavailable

* Virtus LifeSci Biotech Clinical Trials ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.